Credit Suisse’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$356K Sell
15,813
-5,280
-25% -$119K ﹤0.01% 2766
2023
Q4
$452K Sell
21,093
-2,392
-10% -$51.2K ﹤0.01% 2772
2023
Q3
$422K Sell
23,485
-2,463
-9% -$44.2K ﹤0.01% 2758
2023
Q2
$528K Buy
25,948
+4,688
+22% +$95.4K ﹤0.01% 2737
2023
Q1
$463K Buy
21,260
+1,880
+10% +$40.9K ﹤0.01% 2775
2022
Q4
$601K Buy
19,380
+5,549
+40% +$172K ﹤0.01% 2656
2022
Q3
$353K Buy
13,831
+96
+0.7% +$2.45K ﹤0.01% 2983
2022
Q2
$279K Sell
13,735
-680
-5% -$13.8K ﹤0.01% 3182
2022
Q1
$356K Sell
14,415
-288
-2% -$7.11K ﹤0.01% 3133
2021
Q4
$511K Buy
14,703
+1,054
+8% +$36.6K ﹤0.01% 3009
2021
Q3
$371K Buy
13,649
+2,991
+28% +$81.3K ﹤0.01% 3169
2021
Q2
$277K Sell
10,658
-11,238
-51% -$292K ﹤0.01% 3305
2021
Q1
$472K Sell
21,896
-19,194
-47% -$414K ﹤0.01% 2988
2020
Q4
$882K Sell
41,090
-4,539
-10% -$97.4K ﹤0.01% 2642
2020
Q3
$673K Sell
45,629
-29,337
-39% -$433K ﹤0.01% 2509
2020
Q2
$1.68M Buy
74,966
+11,721
+19% +$262K ﹤0.01% 1976
2020
Q1
$894K Sell
63,245
-3,846
-6% -$54.4K ﹤0.01% 2189
2019
Q4
$1.09M Buy
67,091
+45,638
+213% +$741K ﹤0.01% 2447
2019
Q3
$751K Sell
21,453
-14,559
-40% -$510K ﹤0.01% 2579
2019
Q2
$2.03M Buy
36,012
+21,044
+141% +$1.19M ﹤0.01% 1922
2019
Q1
$1.09M Buy
14,968
+1,207
+9% +$88.2K ﹤0.01% 2306
2018
Q4
$878K Buy
13,761
+6,945
+102% +$443K ﹤0.01% 2393
2018
Q3
$680K Sell
6,816
-5,026
-42% -$501K ﹤0.01% 2655
2018
Q2
$842K Sell
11,842
-1,243
-9% -$88.4K ﹤0.01% 2698
2018
Q1
$1.36M Sell
13,085
-3,278
-20% -$341K ﹤0.01% 2360
2017
Q4
$1.65M Buy
16,363
+7,073
+76% +$712K ﹤0.01% 2164
2017
Q3
$324K Buy
+9,290
New +$324K ﹤0.01% 3221